You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Dalteparin

Showing 26 - 50 of 264
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Venous Thromboembolism Trial in Toronto (Prophylactic low molecular weight heparin, Low molecular weight heparin and low-dose

Recruiting
  • Venous Thromboembolism
  • Prophylactic low molecular weight heparin
  • Low molecular weight heparin and low-dose aspirin
  • Toronto, Ontario, Canada
    Mount Sinai Hospital
Jan 18, 2023

LR-ACT and Anti Xa Activity During Endovascular Surgery

Not yet recruiting
  • Aortic Diseases
  • +2 more
  • Anti Xa activity measurement.
  • Bron, France
    Service de chirurgie vasculaire (U50) Hôpital Louis Pradel - HCL
Sep 21, 2022

Cancer Associated Thrombosis for Rivaroxaban - United States

Completed
  • Treatment of Venous Thromboembolism in Cancer Patients
  • Prophylaxis of Recurrent Venous Thromboembolism in Cancer Patients
  • Rivaroxaban (Xarelto, BAY59-7939)
  • +2 more
  • Multiple Locations, Connecticut
    Many Locations
May 18, 2022

Community-acquired Pneumonia Trial in Brazil, Canada, United States (Heparin)

Not yet recruiting
  • Community-acquired Pneumonia
  • Chicago, Illinois
  • +33 more
Apr 28, 2023

Venous Thromboembolism Trial in Denver (Dalteparin sodium, Dalteparin sodium/aspirin)

Completed
Has Results
  • Venous Thromboembolism
  • Dalteparin sodium
  • Dalteparin sodium/aspirin
  • Denver, Colorado
    Denver Health Medical Center
Dec 15, 2018

Venous Thromboembolism (VTE), Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE) Trial in Worldwide (Edoxaban, Dalteparin, Low

Completed
Has Results
  • Venous Thromboembolism (VTE)
  • +3 more
  • Brandon, Florida
  • +8 more
Feb 8, 2019

Venous Thromboembolism, Lung Tumor Trial in France (Tinzaparin Sodium)

Terminated
  • Venous Thromboembolism
  • Lung Neoplasm
  • Tinzaparin Sodium
  • Rennes, Bretagne, France
  • +26 more
Nov 14, 2022

After Tissue Glue for Gastric Varices

Recruiting
  • Anticoagulants and Bleeding Disorders
  • +2 more
  • Low molecular weight heparin
  • Jinan, Shandong, China
    Department of Gastroenterology,Qilu Hospital,Shandong University
Sep 15, 2022

Stroke Trial in Canada, India (Dalteparin, Placebo)

Unknown status
  • Stroke
  • Dalteparin
  • Placebo
  • Halifax, Nova Scotia, Canada
  • +7 more
Feb 18, 2020

Severe Fever With Thrombocytopenia Syndrome Trial in China (Methylprednisolone, intravenous immunoglobulin, Tocilizumab)

Recruiting
  • Severe Fever With Thrombocytopenia Syndrome
  • Guangshui, Hubei, China
  • +9 more
Oct 31, 2022

Gather Information About Rivaroxaban in Sweden With Cancer Who

Active, not recruiting
  • Treatment of Venous Thromboembolism in Cancer Patients
  • Rivaroxaban (Xarelto, BAY59-7939)
  • +3 more
  • Multiple Locations, Many Locations, Sweden
    Swedish registries
Aug 18, 2022

Blood Clot, Trauma Trial in Canada, United States (Acetylsalicylic acid, Low Molecular Weight Heparin (LMWH))

Completed
  • Blood Clot
  • Trauma
  • Acetylsalicylic acid
  • Low Molecular Weight Heparin (LMWH)
  • Tucson, Arizona
  • +20 more
Oct 7, 2022

BMD and Ca-P Metabolism in RSA Patients: LMWH Use Versus Control

Recruiting
  • Recurrent Spontaneous Abortion
  • Low molecular weight heparin
  • Shanghai, Shanghai, China
    Renji Hospital, Shanghai Jiaotong University School of Medicine
May 18, 2023

Tumors, Deep Vein Thrombosis Trial in Houston (Dalteparin (Fragmin))

Terminated
  • Neoplasms
  • Deep Vein Thrombosis
  • Dalteparin (Fragmin)
  • Houston, Texas
    UT MD Anderson Cancer Center
Oct 30, 2018

The Clinical Features and Pregnancy Outcomes of CTD Patients

Recruiting
  • Connective Tissue Diseases
  • Pregnancy Related
  • Jinan, Shandong, China
    Qilu Hospital
Sep 26, 2022

Undifferentiated Connective Tissue Disease, Recurrent Pregnancy Loss Trial in Shanghai (Prednisone, Hydroxychloroquine, Aspirin)

Unknown status
  • Undifferentiated Connective Tissue Disease
  • Recurrent Pregnancy Loss
  • Shanghai, Shanghai, China
    Renji Hospital
Aug 8, 2019

Venous Thrombosis Trial in Worldwide (Shortened duration (6 weeks) of anticoagulant therapy, Conventional duration (3 months) of

Completed
  • Venous Thrombosis
  • Shortened duration (6 weeks) of anticoagulant therapy
  • +2 more
  • Birmingham, Alabama
  • +62 more
Mar 1, 2022

SARS-COV2 Infection, COVID-19 Disease, Hospitalized Patients Trial in Ioánnina (low molecular weight Heparin as standard of care

Completed
  • SARS-COV2 Infection
  • +2 more
  • low molecular weight Heparin as standard of care treatment
  • Ioánnina, Epirus, Greece
    University General Hospital of Ioannina
Sep 27, 2021

Cirrhosis, Splenectomy, Venous Thrombosis Trial in Yangzhou (Apixaban 2.5 MG, Dipyridamole 25Mg Tab, subcutaneous Low Molecular

Recruiting
  • Cirrhosis
  • +3 more
  • Apixaban 2.5 MG
  • +2 more
  • Yangzhou, Jiangsu, China
    Clinical Medical College, Yangzhou University
Apr 30, 2022

Atrial Fibrillation in Patients With Cancer (MAFIC Study)

Recruiting
  • Cancer
  • Atrial Fibrillation
  • Low molecular weight heparin
  • Thessaloniki, Greece
  • +1 more
Feb 14, 2022

COVID-19 Pneumonia Trial in Jinan (Bevacizumab)

Recruiting
  • COVID-19 Pneumonia
  • Jinan, Shandong, China
    Qilu Hospital of Shandong University
Jan 13, 2023

Covid19 Trial in Germany (Anticoagulation Agents (Edoxaban and/or high dose LMWH), Low dose Low molecular weight heparin or

Recruiting
  • Covid19
  • Anticoagulation Agents (Edoxaban and/or high dose LMWH)
  • Low dose Low molecular weight heparin or Placebo
  • Aachen, Germany
  • +9 more
May 16, 2022

COVID-19 Severe Respiratory Failure Trial in Alexandroupolis (Dexamethasone, Low molecular weight heparin, Anakinra 100Mg/0.67Ml

Recruiting
  • COVID-19 Severe Respiratory Failure
  • Alexandroupolis, Evros, Greece
    University Hospital of Alexandroupolis
Mar 11, 2022

Severe COVID-19 Pneumonia Trial in Créteil (Tinzaparin, Low dose prophylactic anticoagulation, Tinzaparin, High dose

Completed
  • Severe COVID-19 Pneumonia
  • Tinzaparin, Low dose prophylactic anticoagulation
  • +2 more
  • Créteil, France
    Henri Mondor Hospital
Sep 5, 2022

Rhegmatogenous Retinal Detachment, High-risk for Proliferative Vitreoretinopathy (PVR) Trial in Germany (5-fluorouracil and low

Completed
  • Rhegmatogenous Retinal Detachment
  • High-risk for Proliferative Vitreoretinopathy (PVR)
  • 5-fluorouracil and low molecular weight heparin
  • Placebo
  • Freiburg, BW, Germany
  • +12 more
Apr 4, 2022